ROIVANT SCIENCES LTD. Current Assets
ROIVANT SCIENCES LTD. (ROIV) had Current Assets of $4.74 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $4.74B.
- 2026-03-31: Assets, Current $5.17B.
- 2025-12-31: Assets, Current $4.66B.
- 2025-09-30: Assets, Current $4.51B.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $4.74B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.17B 10-Q · filed 2026-08-06 |
| 2025-12-31 | $4.66B 10-Q · filed 2026-02-06 |
| 2025-09-30 | $4.51B 10-Q · filed 2025-11-10 |
| 2025-06-30 | $4.62B 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.00B 10-K · filed 2026-05-20 |
| 2024-12-31 | $5.36B 10-Q · filed 2025-02-10 |
| 2024-09-30 | $5.80B 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.00B 10-Q · filed 2024-08-09 |
| 2024-03-31 | $6.73B 10-K · filed 2025-05-29 |
| 2023-12-31 | $6.81B 10-Q · filed 2024-02-13 |
| 2023-09-30 | $1.55B 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.56B 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.80B 10-K · filed 2024-05-30 |
| 2022-12-31 | $1.65B 10-Q · filed 2023-02-13 |
| 2022-09-30 | $1.71B 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.04B 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.15B 10-K · filed 2023-06-28 |
| 2021-12-31 | $2.29B 10-Q · filed 2022-02-14 |
| 2021-09-30 | $2.56B 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.06B 10-Q · filed 2021-09-21 |
| 2021-03-31 | $2.19B 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |